We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$43.3M
(+26%)
Cap. Flow
+$4.36M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
41.81%
Holding
434
New
117
Increased
50
Reduced
37
Closed
98
Avg Time Held Equity + Options
1.2
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.51M |
| 2 |
3D Systems Corp
DDD
|
+$1.4M |
| 3 |
Ciena
CIEN
|
+$953K |
| 4 |
Vince Holding Corp
VNCE
|
+$906K |
| 5 |
Lennar Class A
LEN
|
+$886K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.37M |
| 2 |
Infoblox Inc
BLOX
|
+$1.46M |
| 3 |
Guidewire Software
GWRE
|
+$942K |
| 4 |
Puma Biotechnology
PBYI
|
+$880K |
| 5 |
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.04% |
| 2 | Financials | 25.83% |
| 3 | Healthcare | 10.16% |
| 4 | Consumer Discretionary | 6.24% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Blackstone
BX
$86.2B
| $1.1M | 0.53% |
35,665
-15,285
| -30% | -$417K |
2013 Q2
2 quarters
|
|
27
CALL
Viavi Solutions
VIAV
$10.3B
| $1.04M | 0.5% |
+140,640
| New | +$1.07M |
2013 Q4
0 quarters
|
|
28
Boston Scientific
BSX
$63.5B
| $1.02M | 0.49% |
85,000
+10,000
| +13% | +$118K |
2013 Q2
2 quarters
|
|
29
CALL
ExxonMobil
XOM
$708B
| $1.01M | 0.49% |
+10,000
| New | +$925K |
2013 Q4
0 quarters
|
|
|
30
Lennar Class A
LEN
$17.8B
| $989K | 0.48% |
+26,264
| New | +$886K |
2013 Q4
0 quarters
|
|
31
Halozyme
HALO
$12.6B
| $974K | 0.47% |
65,000
| – | – |
2013 Q2
2 quarters
|
|
|
32
Ciena
CIEN
$57.4B
| $957K | 0.46% |
+40,000
| New | +$953K |
2013 Q4
0 quarters
|
|
33
DELISTED
Farmer Brothers
FARM
| $942K | 0.45% |
40,500
+5,500
| +16% | +$104K |
2013 Q2
2 quarters
|
|
|
COWN
34
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $936K | 0.45% |
59,876
+12,500
| +26% | +$191K |
2013 Q2
2 quarters
|
|
|
35
Vince Holding Corp
VNCE
$145M
| $928K | 0.45% |
+3,025
| New | +$906K |
2013 Q4
0 quarters
|
|
36
Toll Brothers
TOL
$12.2B
| $925K | 0.45% |
+25,000
| New | +$829K |
2013 Q4
0 quarters
|
|
37
DexCom
DXCM
$32.4B
| $885K | 0.43% |
100,000
| – | – |
2013 Q2
2 quarters
|
|
|
PNRA
38
CALL
DELISTED
Panera Bread Co
PNRA
| $883K | 0.43% |
+5,000
| New | +$839K |
2013 Q4
0 quarters
|
|
39
T-Mobile US
TMUS
$163B
| $872K | 0.42% |
25,925
+925
| +4% | +$25.4K |
2013 Q2
2 quarters
|
|
40
RH
RH
$2.21B
| $841K | 0.41% |
12,500
-7,500
| -38% | -$514K |
2013 Q2
2 quarters
|
|
|
FNM
41
DELISTED
FANNIE MAE
FNM
| $828K | 0.4% |
275,000
+175,000
| +175% | +$527K |
2013 Q3
1 quarter
|
|
|
TYC
42
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $821K | 0.4% |
+19,100
| New | +$742K |
2013 Q4
0 quarters
|
|
43
Sarepta Therapeutics
SRPT
$1.84B
| $815K | 0.39% |
40,000
+25,000
| +167% | +$743K |
2013 Q3
1 quarter
|
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $809K | 0.39% |
25,000
-25,917
| -51% | -$769K |
2013 Q3
1 quarter
|
|
45
Burlington
BURL
$16.8B
| $800K | 0.39% |
+25,000
| New | +$699K |
2013 Q4
0 quarters
|
|
46
Blackstone Mortgage Trust
BXMT
$1.83B
| $800K | 0.39% |
29,500
+5,500
| +23% | +$141K |
2013 Q2
2 quarters
|
|
|
RESI
47
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $753K | 0.36% |
25,000
-500
| -2% | -$13.6K |
2013 Q3
1 quarter
|
|
48
BlackBerry
BB
$4.96B
| $744K | 0.36% |
100,000
+50,000
| +100% | +$353K |
2013 Q3
1 quarter
|
|
49
Insulet
PODD
$9.7B
| $742K | 0.36% |
20,000
| – | – |
2013 Q2
2 quarters
|
|
50
Navigator Holdings
NVGS
$1.47B
| $727K | 0.35% |
+27,000
| New | +$628K |
2013 Q4
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2013 Portfolio in Review
As of Q4 2013, E.E. Geduld held 434 positions worth $207M, up 26% from $164M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
E.E. Geduld's Q4 2013 filing shows 117 new, 50 increased, 37 reduced and 98 closed positions. Its largest new stake was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M. The largest sale was PHARMACYCLICS INC, an estimated $2.37M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- E.E. Geduld's largest Q4 2013 buy was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M.
- E.E. Geduld added most to Hess in Q4 2013, an estimated $812K increase.
- E.E. Geduld's biggest Q4 2013 reduction was PHARMACYCLICS INC, cutting an estimated $2.37M.
- E.E. Geduld fully exited Infoblox Inc in Q4 2013, selling an estimated $1.46M.
- E.E. Geduld's ten largest holdings make up 42% of its $207M portfolio in Q4 2013.
- E.E. Geduld opened 117 new positions and closed 98 in Q4 2013.
- E.E. Geduld's portfolio value rose 26% quarter-over-quarter to $207M.
Based on E.E. Geduld's 13F filing for Q4 2013, filed 23 Jan 2014.